Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
09/2014
09/18/2014US20140275285 Metadichol® liquid and gel nanoparticle formulations
09/18/2014US20140275265 Therapeutic cream for application to skin
09/18/2014US20140275263 Microemulsion Topical Delivery Platform
09/18/2014US20140275239 Dronedarone Formulation
09/18/2014US20140275196 Formulations of bendamustine
09/18/2014US20140275184 Cosmetic Compositions and Methods Providing Enhanced Penetration of Skin Care Actives
09/18/2014US20140275151 Dye free liquid therapeutic solution
09/18/2014US20140275148 Orally administrable, self-supporting dissolving film dosage forms
09/18/2014US20140275145 Compositions of a polyorthoester and an aprotic solvent
09/18/2014US20140275144 Morphine formulations
09/18/2014US20140275122 Voriconazole Formulations
09/18/2014US20140275109 Methods for Administering Aripiprazole
09/18/2014US20140275046 Compositions of a polyorthoester and an aprotic solvent
09/18/2014US20140275000 Ceftolozane pharmaceutical compositions
09/18/2014US20140274994 Stabilizing ceftolozane
09/18/2014US20140274992 Ceftolozane pharmaceutical compositions
09/18/2014US20140274991 Ceftolozane pharmaceutical compositions
09/18/2014US20140274982 Topical compositions of flunisolide and methods of treatment
09/18/2014US20140274971 Systems and Methods of Using Chemically Bound Antibiotics Activated by Infections
09/18/2014US20140274951 Ligand-therapeutic agent conjugates, silicon-based linkers, and methods for making and using them
09/18/2014US20140274947 Cyclodextrin-based polymers for therapeutic delivery
09/18/2014US20140274924 Concentrated aqueous azalide formulations
09/18/2014US20140274913 Methods for treating inflammation, autoimmune disorders and pain
09/18/2014US20140274907 Pyrrolobenzodiazepines
09/18/2014US20140274903 Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
09/18/2014US20140274902 Recombinant fviii formulations
09/18/2014US20140274899 Preparations Containing Hepatocyte Growth Factor and Hyaluronic Acid and Methods of Making and Using Same
09/18/2014US20140274888 Conjugate based systems for controlled drug delivery
09/18/2014US20140274877 Hydrochloride salts of an antibiotic compound
09/18/2014US20140274873 Composition of a sustained-release delivery and method of stabilizing proteins during fabrication process
09/18/2014US20140273153 Covalent modification of biological macromolecules
09/18/2014US20140271931 Anti-Acne Topical Films
09/18/2014US20140271921 Pharmaceutical composition
09/18/2014US20140271903 Use of thermo-sensitive gel for controlled delivery of alk-5 inhibitors to the eye and related methods
09/18/2014US20140271892 Phenylephrine resinate particles having good auc
09/18/2014US20140271891 Phenylephrine resinate particles and use thereof in pharmaceutical formulations
09/18/2014US20140271880 Fine dry particulate resveratrol active agent compositions and topical formulations including the same
09/18/2014US20140271879 Fine dry particulate retinoid active agent compositions and topical formulations including the same
09/18/2014US20140271872 Drug delivery system
09/18/2014US20140271866 Transdermal drug delivery system containing rivastigmine
09/18/2014US20140271865 Amphetamine transdermal compositions with acrylic block copolymer
09/18/2014US20140271863 Hot washable poly-n-isopropylacrylamide hydrogel delivery systems
09/18/2014US20140271856 Orally disintegrable tablets
09/18/2014US20140271831 Racecadotril liquid compositions
09/18/2014US20140271826 Kinetin/zeatin topical formulation
09/18/2014US20140271822 Modified docetaxel liposome formulations
09/18/2014US20140271821 Liposomal cisplatin compositions for cancer therapy
09/18/2014US20140271820 Liposome oxaliplatin compositions for cancer therapy
09/18/2014US20140271817 Novel glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
09/18/2014US20140271815 Heat-and freeze-stable vaccines and methods of making and using same
09/18/2014US20140271804 Methods and systems for treating or preventing cancer
09/18/2014US20140271799 Transdermal administration of fentanyl and analogs thereof
09/18/2014US20140271787 Continuous single layer film structure including discrete domains
09/18/2014US20140271764 Bioerodible Silicon-Based Delivery Vehicles for Delivery of Therapeutic Agents
09/18/2014US20140271735 Use of calcitonin in osteoarthritis
09/18/2014US20140271731 Cardiovascular disease treatment and prevention
09/18/2014US20140271724 Methods and compositions for treating or preventing cancer
09/18/2014US20140271715 Compositions and methods for live, attenuated alphavirus formulations
09/18/2014US20140271709 Bovine virus vaccines that are liquid stable
09/18/2014US20140271697 Enhanced expression of picornavirus proteins
09/18/2014US20140271695 Immunogenic lhrh compositions and methods relating thereto
09/18/2014US20140271688 Antibody drug conjugates
09/18/2014US20140271687 Methods of Targeting T-Cells to Tumors
09/18/2014US20140271685 Internalizing human monoclonal antibodies targeting prostate and other cancer cells
09/18/2014US20140271676 Fc containing polypeptides with altered glycosylation and reduced effector function
09/18/2014US20140271640 FGF-10 Complexes
09/18/2014US20140271608 Resorption enhancers as additives to improve the oral formulation of low molecular weight heparins
09/18/2014US20140271607 Blood coagulation factor vii and viia derivatives, conjugates and complexes comprising the same, and use thereof
09/18/2014US20140271605 Stable bioactive substances and methods of making
09/18/2014US20140271601 Crosslinkable trehalose for the covalent incorporation in hydrogels and methods of use
09/18/2014US20140271576 Self-Gelling Alginate Systems and Uses Thereof
09/18/2014US20140271556 Magnetic Acoustic Resonance Light and Homeopathic Therapy Crystal
09/18/2014US20140271530 Curcuminoid complexes with enhanced stability, solubility and/or bioavailability
09/18/2014US20140271529 Antifungal compositions for the treatment of secondary skin and nail infections
09/18/2014US20140271527 Subcutaneous delivery of polymer conjugates of therapeutic agents
09/18/2014US20140271526 Antimicrobial polyamide compositions and mastitis treatment
09/18/2014US20140271483 Targeted polymeric conjugates and uses thereof
09/18/2014US20140271470 Targeted theranostics for metastatic prostate cancer
09/18/2014US20140271466 HSPC-Sparing Treatments for RB-Positive Abnormal Cellular Proliferation
09/18/2014US20140271462 Antigen binding constructs to cd8
09/18/2014US20140271460 Highly Active Anti-Neoplastic and Anti-Proliferative Agents
09/18/2014US20140271458 DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-1 and/or IL-17
09/18/2014US20140271457 Dual Specific Binding Proteins Directed Against TNF
09/18/2014US20140261454 Tinted antiseptic solutions having improved stability
09/18/2014DE102013004263A1 Schnell lösliche orale Darreichungsform und Methode zur Herstellung derselben Quick dissolving oral dosage form and method of manufacturing the same
09/17/2014EP2778167A1 Stable pharmaceutical composition comprising amorphous solifenacin or its pharmaceutically acceptable salt
09/17/2014EP2777715A1 Particles comprising luminescent lanthanide complexes
09/17/2014EP2777714A1 Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme
09/17/2014EP2777713A1 Polyethylene glycol-amino acid oligopeptide-irinotecan drug conjugate and drug composition thereof
09/17/2014EP2777705A1 Ceftolozane antibiotic compositions
09/17/2014EP2777702A1 Stabilized pharmaceutical formulations comprising antineoplastic compounds
09/17/2014EP2777694A1 Hypoxia-Targeted Polymeric Micelles for Cancer Therapy and Imaging
09/17/2014EP2777693A1 Biodegradable ocular implants with long-term release characteristics
09/17/2014EP2777692A1 Composition for enhancing transdermal absorption of drug and patch preparation
09/17/2014EP2777691A1 Taxoid - Purification of Liquid Excipients
09/17/2014EP2777689A1 New pharmaceutical composition for the treatment of fungal infections
09/17/2014EP2776471A1 Stable peptide-based furin inhibitors
09/17/2014EP2776470A2 Antibodies specific for trop-2 and their uses
09/17/2014EP2776070A1 Immunomodulatory conjugates
09/17/2014EP2776069A1 Carrier molecule comprising a spr0096 and a spr2021 antigen
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 1712